| Age(years) |
|
|
0.06 |
|
|
0.044 |
| ≤25 |
3 |
5 (4-5) |
|
3 |
100 (75-100)* |
|
| >25 |
259 |
9 (0-32) |
|
248 |
71.4 (10-100)* |
|
| BMI (kg/m2) |
|
|
0.21 |
|
|
0.378 |
| 18-24.9 |
225 |
9 (0-26) |
|
216 |
70.85±17.89 |
|
| ≥ 25 |
37 |
9 (0-32) |
|
35 |
67.94±18.93 |
|
| AMH (ng/ml) |
|
|
0.24 |
|
|
0.536 |
| <5 |
165 |
9 (0-32) |
|
160 |
69.91±18.11 |
|
| ≥5 |
97 |
10 (0-26) |
|
91 |
71.38±17.95 |
|
| Baseline Serum FSH (mIU/ml) |
|
|
0.05 |
|
|
0.431 |
| <4 (n=115) |
115 |
10 (0-26) |
|
111 |
69.31±17.99 |
|
| 5-8 (n=134) |
134 |
9 (0-32) |
|
128 |
70.90±18.36 |
|
| >8 (n=13) |
13 |
8 (0-14) |
|
12 |
76.06±14.48 |
|
| Starting dose of FSH (IU) |
|
|
0.03 |
|
|
0.164 |
| 100-150 |
42 |
9 (0-26) |
|
41 |
71.38±15.10 |
|
| 151-200 |
61 |
10 (0-26) |
|
58 |
68.52±17.00 |
|
| 201-250 |
86 |
10 (0-32) |
|
82 |
67.96±20.37 |
|
| 251-300 |
62 |
9 (0-20) |
|
59 |
73.54±17.49 |
|
| >300 |
11 |
7 (2-111) |
|
11 |
78.93±14.90 |
|
| Total FSH (IU) |
|
|
0.001 |
|
|
0.043 |
| <2000 |
73 |
8 (0-26) |
|
72 |
71.65±18.31 |
|
| 2001-3000 |
128 |
11 (0-32) |
|
124 |
69.19±17.27 |
|
| 3001- 4000 |
41 |
9 (0-20) |
|
38 |
67.41±18.87 |
|
| >4000 |
19 |
7 (0-17) |
|
17 |
81.22±17.70 |
|
| Duration of stimulation (days) |
|
|
0.205 |
|
|
0.907 |
| <10 |
164 |
9 (0-26) |
|
157 |
70.34±17.25 |
|
| ≥11 |
98 |
9 (0-32) |
|
94 |
70.61±19.36 |
|
| Serum estradiol on day of trigger(pg/ml) |
|
|
0.0001 |
|
|
0.193 |
| 1001-3000 |
103 |
8 (0-32) |
|
96 |
68.87±21.01 |
|
| ≤1000 |
11 |
3 (0-6) |
|
8 |
80.42±16.91 |
|
| >3000 |
148 |
11 (2-26) |
|
147 |
70.93±15.76 |
|